Tongue ultrasonography as a quantitative biomarker for oropharyngeal dysphagia in neuromuscular disorders: a systematic review
European Journal of Translational Myology · 13.11.2026
DOI: 10.4081/ejtm.2026.16288 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Translational Myology, online erschienen am 13.11.2026. Verfasst von Maria Chiara Maccarone und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Rehabilitation, Department of Neuroscience-DNS, University of Padova. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Dysphagie
Abstract (Originalsprache)
Oropharyngeal Dysphagia (OD) is a prevalent and potentially life-threatening complication of Neuromuscular Disorders (NMDs). Tongue ultrasonography is an inexpensive, non-ionising, point-of-care technique that permits quantitative assessment of lingual muscle structure, but its value as a biomarker of OD across NMDs has not been systematically appraised. This systematic review aims to synthesize the available evidence on the diagnostic accuracy, reliability and clinical utility of quantitative tongue ultrasonography as a biomarker of OD in adults with NMDs. We systematically searched PubMed and Scopus for studies correlating quantitative tongue-ultrasound parameters, Tongue Thickness (TT) or Echo Intensity (EI), with instrumental swallowing assessment in adults with NMDs, following the PRISMA 2020 guideline. Study selection, data extraction and risk-of-bias appraisal were performed independently by two reviewers. Six studies (n = 10-38 per cohort) met the inclusion criteria. Reduced TT was a consistent marker of lingual atrophy in Amyotrophic Lateral Sclerosis (ALS) and correlated with oral-phase swallowing impairment, whereas functional measures of tongue strength were stronger predictors of aspiration risk. In Duchenne Muscular Dystrophy (DMD), increased TT reflected "pseudohypertrophy" from fatty and connective-tissue infiltration rather than preserved function and EI provided a complementary index of tissue quality in myopathic NMDs. Tongue ultrasonography is a promising, disease-sensitive biomarker for monitoring bulbar dysfunction in NMDs, but morphological indices should be integrated with functional swallowing data to predict aspiration risk. Standardized acquisition protocols and larger, longitudinal, multicentre studies are required before clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Rehabilitation, Department of Neuroscience-DNS, University of Padova.
- Physical and Rehabilitation Medicine, Department of Clinical Sciences and Translational Medicine, Tor Vergata University, Rome.
- 2nd Physical Medicine and Rehabilitation Department, National Rehabilitation Center EKA (Ethniko Kentro Apokatastasis), Athens.
ORCID-Profile: Maria Chiara Maccarone, Nicola Manocchio, Yannis Dionyssiotis
Zitieren
APA
Maccarone, M. C., Manocchio, N., Foti, C., & Dionyssiotis, Y. (2026). Tongue ultrasonography as a quantitative biomarker for oropharyngeal dysphagia in neuromuscular disorders: a systematic review. European Journal of Translational Myology. https://doi.org/10.4081/ejtm.2026.16288
Vancouver
Maccarone MC, Manocchio N, Foti C, Dionyssiotis Y. Tongue ultrasonography as a quantitative biomarker for oropharyngeal dysphagia in neuromuscular disorders: a systematic review. European Journal of Translational Myology. 2026. doi:10.4081/ejtm.2026.16288
BibTeX
@article{Maccarone2026,
author = {Maccarone, Maria Chiara and Manocchio, Nicola and Foti, Calogero and Dionyssiotis, Yannis},
title = {Tongue ultrasonography as a quantitative biomarker for oropharyngeal dysphagia in neuromuscular disorders: a systematic review},
journal = {European Journal of Translational Myology},
year = {2026},
doi = {10.4081/ejtm.2026.16288}
}
EUVIMED